Originally Posted by
Darkoz
If Cytodyn bottoms out I understood and accepted the risks. No risk, no reward.
And until I sell, the stock game isn't over.
True enough, but that sounds like pride.
You do have options. If you have conviction, buying more while on sale and hoping for a bounce is an option. I haven't done my due diligence on the company to recommend that though. Selling and moving on is another.
Many years ago I rode a company all the way down through being untradable to BK. Kept waiting for any good news. Without positive earnings mgmt. had to do secondaries, incur more debt. The cash burn became a death spiral.
You always hope for a buyout with biotechs, but I think it's fair to say that competitors and or big Bio know what you have already and if it would be worthwhile to acquire.